Medicaid Expansion Linked to Lower Mortality in Young Adult Dialysis Patients

Insurance Status and Survival in Young Adult Kidney Failure

Chronic kidney disease represents a substantial global health burden, affecting approximately 13.4% of the population and serving as a major independent risk factor for cardiovascular morbidity and premature death [1, 2]. For patients progressing to kidney failure, the initiation of maintenance dialysis marks a period of extreme physiological vulnerability where intensive management of blood pressure and cardiovascular risk is paramount [3, 4]. Despite advancements in dialysis modalities and care bundles designed to prevent acute complications, mortality rates remain high during the transition to renal replacement therapy [5, 6]. Clinical outcomes in this population are often dictated not only by biological factors but also by the consistency of specialized nephrology oversight and the adequacy of the dialysis prescription [7, 8]. A recent study examines how systemic policy changes in healthcare coverage, specifically the Affordable Care Act, influence these critical survival metrics for young adults entering the dialysis system.

Comparative Analysis of Post-Expansion Outcomes

To evaluate the impact of the Affordable Care Act (ACA) Medicaid expansion, researchers utilized a quasi-experimental difference-in-differences design (a statistical method that compares outcome changes over time between a group affected by a policy and an unaffected control group). The study focused on a total cohort of 7139 patients residing in states that expanded Medicaid. Spanning from January 1, 2010, to December 31, 2019, the analysis captured clinical data before and after the implementation of the expansion provisions to assess their influence on patient survival. The investigation compared two distinct age groups to isolate the policy's impact. The primary group consisted of 4791 young adults aged 19 to 23 years, a population directly affected by the expansion of Medicaid eligibility. This group included 2717 male patients (56.7%) and 2074 female patients (43.3%). The comparison group, which maintained unchanged eligibility throughout the study period, comprised 2348 adolescents aged 14 to 18 years. Within this younger cohort, there were 1280 male patients (54.5%) and 1068 female patients (45.5%). The primary outcome measured was 1-year mortality from the date of dialysis initiation, a critical window for patients with kidney failure. By comparing the 19- to 23-year-old cohort against the 14- to 18-year-old group, the authors aimed to determine if increased access to Medicaid coverage translated into improved survival rates during the first year of renal replacement therapy. This approach allowed the researchers to account for broader trends in dialysis care while specifically identifying the survival benefits associated with expanded health insurance coverage for young adults.

Significant Reductions in One-Year Mortality

The researchers observed a substantial improvement in survival outcomes for the young adult cohort following the implementation of Medicaid expansion. For patients aged 19 to 23 years, 1-year mortality declined from 3.6% (95% CI, 2.4% to 4.9%) in the pre-expansion period to 2.1% (95% CI, 1.2% to 3.0%) after expansion. This represents a mortality change of -1.5 percentage points (95% CI, -2.5 to -0.6) for this specific age group. These figures suggest that the policy change directly correlated with a reduction in early deaths among young adults who were just beginning dialysis, a period often characterized by high clinical instability and cardiovascular risk. In contrast, the comparison group of adolescents aged 14 to 18 years, whose insurance eligibility remained largely unchanged by the policy, did not experience a similar survival benefit. The concurrent mortality for 14- to 18-year-olds was 0.7% (95% CI, 0.3% to 1.0%) pre-expansion and 1.1% (95% CI, 0.5% to 1.7%) post-expansion, reflecting a mortality change of 0.4 percentage points (95% CI, -0.3 to 1.1). To isolate the specific effect of the Medicaid expansion from other temporal trends in renal care, the authors calculated an adjusted difference-in-difference estimate for mortality of -1.8 percentage points (95% CI, -2.9 to -0.7). For practicing nephrologists and primary care physicians, this nearly 2 percentage point absolute reduction in the risk of death during the first year of dialysis underscores how continuous insurance coverage can mitigate the extreme physiological and logistical vulnerabilities patients face when transitioning to end-stage renal care.

Shifts in Coverage and Clinical Care Delivery

To identify the mechanisms underlying the observed survival benefits, the researchers evaluated several secondary outcomes, including Medicaid coverage, uninsurance, predialysis nephrology care, prescribed hemodialysis duration, modality of dialysis, and catheter use. Among the young adult cohort aged 19 to 23 years, Medicaid coverage increased from 37.1% to 48.5% following the expansion, while uninsurance rates declined from 19.4% to 7.8%. After accounting for concurrent changes among the 14- to 18-year-old control group, the adjusted difference-in-difference estimate for Medicaid coverage was 8.4 percentage points (95% CI, 4.8 to 12.0), and the adjusted difference-in-difference estimate for uninsurance was -9.1 percentage points (95% CI, -12.4 to -5.8). These shifts in insurance status were accompanied by measurable changes in how clinical care was delivered to young adults initiating dialysis. The study found that Medicaid expansion was associated with higher rates of predialysis nephrology care, which is critical for managing the complications of advanced kidney disease before the urgent transition to renal replacement therapy. Furthermore, the expansion was associated with higher rates of prescribed hemodialysis sessions of 4 or more hours and higher use of peritoneal dialysis, a home-based treatment modality that often preserves residual kidney function longer. However, the researchers noted that Medicaid expansion was not associated with use of catheters for hemodialysis or with kidney transplant rates. These findings suggest that while improved insurance coverage facilitates better access to adequate maintenance dialysis and predialysis management (factors that likely drive the observed mortality reduction), it may not immediately overcome the complex systemic barriers associated with surgical vascular access placement or the organ procurement process.

References

1. Hill NR, Fatoba S, Oke J, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS ONE. 2016. doi:10.1371/journal.pone.0158765

2. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016. doi:10.1136/bmj.i4482

3. Group TSR. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine. 2015. doi:10.1056/nejmoa1511939

4. Perkovic V, Jardine M, Neal B, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. New England Journal of Medicine. 2019. doi:10.1056/nejmoa1811744

5. Pyne L, Rossignol P, Giles C, et al. Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials.. Lancet (London, England). 2025. doi:10.1016/S0140-6736(25)01153-5

6. Meersch M, Schmidt CG, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Medicine. 2017. doi:10.1007/s00134-016-4670-3

7. Wang AY, Ninomiya T, Al-Kahwa A, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014. doi:10.1053/j.ajkd.2014.01.435

8. Nistor I, Palmer SC, Craig JC, et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014. doi:10.1053/j.ajkd.2013.12.004